ADMA Biologics, Inc. (ADMA)
9.39
+0.05
(+0.54%)
USD |
NASDAQ |
Aug 31, 16:00
9.385
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Total Long Term Debt (Quarterly) : 202.66M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 202.66M |
| March 31, 2026 | 203.23M |
| December 31, 2025 | 78.79M |
| September 30, 2025 | 81.82M |
| June 30, 2025 | 82.70M |
| March 31, 2025 | 80.82M |
| December 31, 2024 | 80.90M |
| September 30, 2024 | 110.19M |
| June 30, 2024 | 140.26M |
| March 31, 2024 | 140.33M |
| December 31, 2023 | 140.37M |
| September 30, 2023 | 151.99M |
| June 30, 2023 | 150.53M |
| March 31, 2023 | 154.77M |
| December 31, 2022 | 153.54M |
| September 30, 2022 | 152.00M |
| June 30, 2022 | 150.68M |
| March 31, 2022 | 145.71M |
| December 31, 2021 | 102.33M |
| September 30, 2021 | 101.28M |
| June 30, 2021 | 100.95M |
| March 31, 2021 | 99.83M |
| December 31, 2020 | 97.30M |
| September 30, 2020 | 99.90M |
| June 30, 2020 | 99.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 97.96M |
| December 31, 2019 | 84.50M |
| September 30, 2019 | 84.09M |
| June 30, 2019 | 83.77M |
| March 31, 2019 | 57.23M |
| December 31, 2018 | 44.22M |
| September 30, 2018 | 43.94M |
| June 30, 2018 | 43.66M |
| March 31, 2018 | 43.23M |
| December 31, 2017 | 42.97M |
| September 30, 2017 | 31.16M |
| June 30, 2017 | 32.64M |
| March 31, 2017 | 19.33M |
| December 31, 2016 | 20.26M |
| September 30, 2016 | 20.07M |
| June 30, 2016 | 19.88M |
| March 31, 2016 | 15.86M |
| December 31, 2015 | 15.73M |
| September 30, 2015 | 15.60M |
| June 30, 2015 | 15.48M |
| March 31, 2015 | 15.09M |
| December 31, 2014 | 14.97M |
| September 30, 2014 | 10.06M |
| June 30, 2014 | 9.911M |
| March 31, 2014 | 9.881M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Erasca, Inc. | 39.27M |
| Krystal Biotech, Inc. | 7.045M |
| Vericel Corp. | 80.41M |
| Emergent BioSolutions, Inc. | 586.70M |
| Exelixis, Inc. | 165.93M |